[1] Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med, 2001, 344(7): 501-509.
[2] Duntas LH. Thyroid disease and lipids. Thyroid, 2002, 12(4): 287- 293.
[3] Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine, 2004, 24(1): 1-13.
[4] Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983, 51(3): 606.
[5] Miura S, Iitaka M, Suzuki S, et al. Decrease in serum levels of thyroid hormone in patients with coronary heart disease. Endocr J, 1996, 43(6): 657-663.
[6] Müller B, Tsakiris DA, Roth CB, et al. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest, 2001, 31(2): 131-137.
[7] Pretnar-Oblak J, Sebestjen M, Sabovic M. Statin treatment improves cerebral more than systemic endothelial dysfunction in patients with arterial hypertension. Am J Hypertens, 2008, 21(6): 674-678.
[8] De Pergola G, Ciampolillo A, Paolotti S, et al. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol(Oxf), 2007, 67(2): 265-269.
[9] Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab, 2005, 90(7): 4019-4024.
[10] Iqbal A, Figenschau Y, Jorde R. Blood pressure in relation to serum thyrotropin: the Tromso study. J Hum Hypertens, 2006, 20(12): 932-936.
[11] Park HT, Cho GJ, Ahn KH, et al. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas, 2009, 62(3): 301-305.
[12] Asvold BO, Vatten LJ, Nilsen TI, et al. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol, 2007, 156(2): 181-186.
[13] Dullaart RP, de Vries R, Roozendaal C, et al. Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects. Clin Endocrinol(Oxf), 2007, 67(5): 668-673.
[14] Roos A, Bakker SJ, Links TP, et al. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab, 2007, 92(2): 491-496.
[15] Tatar E, Kircelli F, Asci G, et al. Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients. Clin J Am Soc Nephrol, 2011, 6(9): 2240-2246.
[16] Coceani M, Iervasi G, Pingitore A, et al. Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications. Clin Cardiol, 2009, 32(7): 380-385.
[17] 陈志奎, 胡申江, 刘春霞, 等.冠心病患者的血清甲状腺激素水平.中国内分泌代谢杂志, 2004, 20(2): 143-144.
[18] Pingitore A, Landi P, Taddei MC, et al. Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med, 2005, 118(2): 132-136.
[19] Iervasi G, Landi P, Raciti M, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation, 2003, 107(5): 708-713.
[20] Ertas F, Kaya H, Soydinc MS. Low serum free triiodothyronine levels are associated with the presence and severity of coronary artery disease in the euthyroid patients: an observational study. Anadolu Kardiyol Derg, 2012, 12(7): 591-596.